Who Paid My Doc
A Phase 2B Single Arm, Repeat Dose Study to Evaluate the Pharmacokinet
Research payments
$5,964,162
Through program year 2025, $5,964,162 in research payments was reported against A Phase 2B Single Arm, Repeat Dose Study to Evaluate the Pharmacokinet, across 569 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $5,918,279 | 558 |
| 2024 | Research | $45,884 | 11 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Javier Morales Ramirez Santurce, PR Named on 68 payments
- Anthony Mills West Hollywood, CA Named on 42 payments
- Abid Chaudhry Doral, FL Named on 36 payments
- Peter Ruane Los Angeles, CA Named on 34 payments
- Ashraf Zadshir Rancho Mirage, CA Named on 32 payments
- Cornelius Van Dam Greensboro, NC Named on 30 payments
- Michael Olek Las Vegas, NV Named on 28 payments
- Charlotte-Paige Rolle Orlando, FL Named on 26 payments
- Olayemi Osiyemi West Palm Beach, FL Named on 24 payments
- Carl Fichtenbaum Cincinnati, OH Named on 23 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.